Factors associated with decreasing serum 25(OH)D among Japanese patients with rheumatoid arthritis: Results from the IORRA cohort study

References

• Baker JF, Baker DG, Toedter G, Shults J, Von Feldt JM, Leonard MB. Associations between vitamin D, disease activity, and clinical response to therapy in rheumatoid arthritis. Clin Exp Rheumatol. 2012;30:658–64.
   PubMed Web of Science ®Google Scholar
• Kerr GS, Sabahi I, Richards JS, Caplan L, Cannon GW, Reimold A, et al. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J Rheumatol. 2011;38(1):53–9.
   PubMed Web of Science ®Google Scholar
• Rossini M, Maddali Bongi S, La Montagna G, Minisola G, Malavolta N, Bernini L, et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther. 2010;12(6):R216.
   PubMed Web of Science ®Google Scholar
• Craig SM, Yu F, Curtis JR, Alarcon GS, Conn DL, Jonas B, et al. Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J Rheumatol. 2010;37:275–81.
   PubMed Web of Science ®Google Scholar
• Avouac J, Koumakis E, Toth E, Meunier M, Maury E, Kahan A, et al. Increased risk of osteoporosis and fracture in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Arthritis Care Res. 2012;64(12):1871–8.
   PubMed Web of Science ®Google Scholar
• Furuya T, Hosoi T, Tanaka E, Nakajima A, Taniguchi A, Momohara S, et al. Prevalence of and factors associated with vitamin D deficiency in 4,793 Japanese patients with rheumatoid arthritis. Clin Rheumatol. 2013;32(7):1081.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Sugioka Y, Tada M, Okano T, Mamoto K, Inui K, et al. Relationships between serum 25-hydroxycalciferol, vitamin D intake and disease activity in patients with rheumatoid arthritis – TOMORROW study. Mod Rheumatol. 2015;25(2):246–50.
   PubMed Web of Science ®Google Scholar
• Hong Q, Xu J, Xu S, Lian L, Zhang M, Ding C. Associations between serum 25-hydroxyvitamin D and disease activity, inflammatory cytokines and bone loss in patients with rheumatoid arthritis. Rheumatology. 2014;53(11):1994–2001.
   PubMed Web of Science ®Google Scholar
• Baker JF, Mehta NN, Baker DG, Toedter G, Shults J, Von Feldt JM, et al. Vitamin D, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritis. Am J Med. 2012;125(10):1036 e9–15.
   Web of Science ®Google Scholar
• Yang J, Liu L, Zhang Q, Li M, Wang J. Effect of vitamin D on the recurrence rate of rheumatoid arthritis. Exp Ther Med. 2015;10(5):1812–16.
   PubMed Web of Science ®Google Scholar
• Quintana-Duque MA, Caminos JE, Varela-Narino A, Calvo-Paramo E, Yunis JJ, Iglesias-Gamarra A. The role of 25-hydroxyvitamin D as a predictor of clinical and radiological outcomes in early onset rheumatoid arthritis. J Clin Rheumatol. 2017;23(1):33–9.
   PubMed Web of Science ®Google Scholar
• Di Franco M, Barchetta I, Iannuccelli C, Gerardi MC, Frisenda S, Ceccarelli F, et al. Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up study. BMC Musculoskelet Disord. 2015;16(1):53.
   PubMedGoogle Scholar
• Ochi K, Furuya T, Ikari K, Taniguchi A, Yamanaka H, Momohara S. Association between serum vitamin D level and history of falls in elderly Japanese patients with rheumatoid arthritis. Mod Rheumatol. 2016;26(3):460–2.
   PubMed Web of Science ®Google Scholar
• Furuya T, Inoue E, Hosoi T, Taniguchi A, Momohara S, Yamanaka H. Risk factors associated with the occurrence of hip fracture in Japanese patients with rheumatoid arthritis: a prospective observational cohort study. Osteoporos Int. 2013;24(4):1257–65.
   PubMed Web of Science ®Google Scholar
• Ochi K, Go Y, Furuya T, Ikari K, Taniguchi A, Yamanaka H, et al. Risk factors associated with the occurrence of distal radius fractures in Japanese patients with rheumatoid arthritis: a prospective observational cohort study. Clin Rheumatol. 2014;33(4):477–83.
   PubMed Web of Science ®Google Scholar
• Ishida O, Furuya T, Inoue E, Ochi K, Ikari K, Taniguchi A, et al. Risk factors for established vertebral fractures in Japanese patients with rheumatoid arthritis: results from a large prospective observational cohort study. Mod Rheumatol. 2015;25(3):373–8.
   PubMed Web of Science ®Google Scholar
• Ochi K, Furuya T, Ishibashi M, Watanabe M, Ikari K, Taniguchi A, et al. Risk factors associated with the occurrence of proximal humerus fractures in patients with rheumatoid arthritis: a custom strategy for preventing proximal humerus fractures. Rheumatol Int. 2016;36(2):213–19.
   PubMed Web of Science ®Google Scholar
• Furuya T, Yamagiwa K, Ikai T, Inoue E, Taniguchi A, Momohara S, et al. Associated factors for falls and fear of falling in Japanese patients with rheumatoid arthritis. Clin Rheumatol. 2009;28(11):1325–30.
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.
   PubMed Web of Science ®Google Scholar
• Okazaki R, Ozono K, Fukumoto S, Inoue D, Yamauchi M, Minagawa M, et al. Assessment criteria for vitamin D deficiency/insufficiency in Japan: proposal by an expert panel supported by the Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society [Opinion]. J Bone Miner Metab. 2017;35:1–5.
   PubMed Web of Science ®Google Scholar
• Haque UJ, Bartlett SJ. Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clin Exp Rheumatol. 2010;28(5):745–7.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Uchiyama S, Kamimura M, Ikegami S, Komatsu M, Kato H. Increased serum 25(OH)D3 levels in post-menopausal Japanese women with osteoporosis after 3-year bisphosphonate treatment. Tohoku J Exp Med. 2017;242(3):241–6.
   PubMed Web of Science ®Google Scholar
• Mawatari T, Muraoka R, Iwamoto Y. Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials. Osteoporos Int. 2017;28(4):1279–86.
   PubMed Web of Science ®Google Scholar
• Ishijima M, Sakamoto Y, Yamanaka M, Tokita A, Kitahara K, Kaneko H, et al. Minimum required vitamin D level for optimal increase in bone mineral density with alendronate treatment in osteoporotic women. Calcif Tissue Int. 2009;85(5):398–404.
   PubMed Web of Science ®Google Scholar
• Takano T, Kondo S, Saito H, Matsumoto T, Eldecalcitol Study G. Relationship between the effect of eldecalcitol and serum 25(OH)D level. J Steroid Biochem Mol Biol. 2014;144PtA:124–7.
   Google Scholar
• Omata Y, Hagiwara F, Nishino J, Matsudaira K, Kadono Y, Juji T, et al. Vertebral fractures affect functional status in postmenopausal rheumatoid arthritis patients. J Bone Miner Metab. 2014;32(6):725–31.
   PubMed Web of Science ®Google Scholar